Esketamine nasal and Oxybutynin Extended-Release Tablets
Determining the interaction of Esketamine nasal and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esketamine
Brand name: Spravato
Synonyms: Esketamine (nasal), Esketamine
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Esketamine nasal-Oxybutynin Gel
- Esketamine nasal-Oxybutynin Oral Solution
- Esketamine nasal-Oxybutynin Syrup
- Esketamine nasal-Oxybutynin Tablets
- Esketamine nasal-Oxybutynin transdermal
- Esketamine nasal-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Eslicarbazepine
- Oxybutynin Extended-Release Tablets-Eslicarbazepine Acetate
- Oxybutynin Extended-Release Tablets-Esmolol
- Oxybutynin Extended-Release Tablets-Esmolol HCl
- Oxybutynin Extended-Release Tablets-Esmolol Hydrochloride
- Oxybutynin Extended-Release Tablets-Esmolol Injection